Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding: a meta-analysis assessment.
Merkel
C
C
Morabito
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D015911:Sclerotherapy; D014648:Varicose Veins / Q000150:complications* / Q000628:therapy*
D000319:Adrenergic beta-Antagonists